These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 22402886)
1. Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma. Kikuchi M; Nakamoto Y; Shinohara S; Fujiwara K; Yamazaki H; Kanazawa Y; Kurihara R; Kishimoto I; Harada H; Naito Y Int J Clin Oncol; 2013 Jun; 18(3):402-10. PubMed ID: 22402886 [TBL] [Abstract][Full Text] [Related]
2. Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma. Kikuchi M; Shinohara S; Nakamoto Y; Usami Y; Fujiwara K; Adachi T; Hori SY; Tona Y; Yamazaki H; Imai Y; Naito Y Mol Imaging Biol; 2011 Apr; 13(2):368-77. PubMed ID: 20552285 [TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pretreatment 18F-FDG PET/CT parameters including visual evaluation in patients with head and neck squamous cell carcinoma. Koyasu S; Nakamoto Y; Kikuchi M; Suzuki K; Hayashida K; Itoh K; Togashi K AJR Am J Roentgenol; 2014 Apr; 202(4):851-8. PubMed ID: 24660716 [TBL] [Abstract][Full Text] [Related]
4. Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? Castaldi P; Rufini V; Bussu F; Miccichè F; Dinapoli N; Autorino R; Lago M; De Corso E; Almadori G; Galli J; Paludetti G; Giordano A; Valentini V Radiother Oncol; 2012 Apr; 103(1):63-8. PubMed ID: 22459579 [TBL] [Abstract][Full Text] [Related]
5. A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck. Adkins D; Ley J; Dehdashti F; Siegel MJ; Wildes TM; Michel L; Trinkaus K; Siegel BA Cancer Med; 2014 Dec; 3(6):1493-501. PubMed ID: 25081631 [TBL] [Abstract][Full Text] [Related]
6. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593 [TBL] [Abstract][Full Text] [Related]
7. FDG PET/CT and diffusion-weighted imaging of head and neck squamous cell carcinoma: comparison of prognostic significance between primary tumor standardized uptake value and apparent diffusion coefficient. Nakajo M; Nakajo M; Kajiya Y; Tani A; Kamiyama T; Yonekura R; Fukukura Y; Matsuzaki T; Nishimoto K; Nomoto M; Koriyama C Clin Nucl Med; 2012 May; 37(5):475-80. PubMed ID: 22475897 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma. Abgral R; Le Roux PY; Rousset J; Querellou S; Valette G; Nowak E; Turzo A; Tissot V; Marianowski R; Salaün PY Nucl Med Commun; 2013 Jun; 34(6):551-6. PubMed ID: 23587836 [TBL] [Abstract][Full Text] [Related]
9. Preoperative Contrast-Enhanced CT Versus ¹⁸F-FDG PET/CT Evaluation and the Prognostic Value of Extranodal Extension for Surgical Patients with Head and Neck Squamous Cell Carcinoma. Lee JR; Choi YJ; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1020-7. PubMed ID: 26122372 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535 [TBL] [Abstract][Full Text] [Related]
11. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value. Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108 [TBL] [Abstract][Full Text] [Related]
12. The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. Wong KH; Panek R; Welsh L; Mcquaid D; Dunlop A; Riddell A; Murray I; Du Y; Chua S; Koh DM; Bhide S; Nutting C; Oyen WJ; Harrington K; Newbold KL J Nucl Med; 2016 Dec; 57(12):1843-1850. PubMed ID: 27417648 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status. Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445 [TBL] [Abstract][Full Text] [Related]
14. Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma. Abgral R; Le Roux PY; Keromnes N; Rousset J; Valette G; Gouders D; Leleu C; Mollon D; Nowak E; Querellou S; Salaün PY Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1839-47. PubMed ID: 22895863 [TBL] [Abstract][Full Text] [Related]
15. Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer. Groheux D; Hindié E; Giacchetti S; Hamy AS; Berger F; Merlet P; de Roquancourt A; de Cremoux P; Marty M; Hatt M; Espié M Eur J Cancer; 2014 Jul; 50(11):1864-71. PubMed ID: 24841218 [TBL] [Abstract][Full Text] [Related]
16. Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features. Wray R; Sheikhbahaei S; Marcus C; Zan E; Ferraro R; Rahmim A; Subramaniam RM AJR Am J Roentgenol; 2016 Sep; 207(3):641-7. PubMed ID: 27341273 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma. Lee SJ; Choi JY; Lee HJ; Baek CH; Son YI; Hyun SH; Moon SH; Kim BT Korean J Radiol; 2012; 13(6):752-9. PubMed ID: 23118574 [TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of (18)F-fluorodeoxyglucose Positron Emission Tomography (FDG-PET)-Positive Lymph Nodes Following Neoadjuvant Chemotherapy and Surgery for Resectable Thoracic Esophageal Squamous Cell Carcinoma. Yasuda T; Yano M; Miyata H; Yamasaki M; Takiguchi S; Fujiwara Y; Doki Y Ann Surg Oncol; 2015 Aug; 22(8):2599-607. PubMed ID: 25524011 [TBL] [Abstract][Full Text] [Related]
19. Influence of volumetric 4'-[methyl- Hoshikawa H; Mori T; Maeda Y; Takahashi S; Ouchi Y; Yamamoto Y; Nishiyama Y Ann Nucl Med; 2017 Jan; 31(1):63-70. PubMed ID: 27679399 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of (18)F-fluorodeoxyglucose uptake before treatment for pharyngeal cancer. Suzuki H; Kato K; Fujimoto Y; Itoh Y; Hiramatsu M; Naganawa S; Hasegawa Y; Nakashima T Ann Nucl Med; 2014 May; 28(4):356-62. PubMed ID: 24515867 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]